REVOLUTION MEDICINES INC *W EXP 12/17/202

REVOLUTION MEDICINES INC *W EXP 12/17/202 is a security (CUSIP 76155X118) tracked across SEC portfolio filings. 25 institutional managers reported $16.8M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $891K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 25 managers by value.

ManagerLocationValueShares
LMR Partners LLPLONDON, X0$6.9M3,838,024
D. E. Shaw & Co., Inc.New York, NY$2.7M1,580,345
Sculptor Capital LPNew York, NY$1.7M958,822
ARISTEIA CAPITAL LLCGREENWICH, CT$1.0M583,615
Caption Management, LLCOKLAHOMA CITY, OK$927K517,685
ADAGE CAPITAL PARTNERS GP, L.L.C.Boston, MA$895K500,000
PERCEPTIVE ADVISORS LLCNEW YORK, NY$448K250,000
TD Asset Management IncToronto, A6$382K40,636
Bleichroeder LPNEW YORK, NY$358K200,000
WOLVERINE ASSET MANAGEMENT LLCCHICAGO, IL$306K170,698
CSS LLC/ILCHICAGO, IL$282K17,505
Davidson Kempner Capital Management LPNew York, NY$261K150,000
FARALLON CAPITAL MANAGEMENT LLCSAN FRANCISCO, CA$209K120,085
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$155K
Weiss Asset Management LPBOSTON, MA$128K73,640

Top fund holders (N-PORT)

FundRegistrantValue% of fund
T. Rowe Price New Horizons Fund, Inc.T. ROWE PRICE NEW HORIZONS FUND, INC.$527K0.41%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$345K0.32%
T. Rowe Price Health Sciences PortfolioT. ROWE PRICE EQUITY SERIES, INC.$19K0.29%

More